Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Frederic Colombel

Showing results (401-410 of 463) with videos related to

Pageof 47
Sort By:
Gastroenterology|May 7, 2020
Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated DiseasesEli Stahl, Giulia Roda, Amanda Dobbyn, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
Defined microbiota transplant restores Th17/RORγt<sup>+</sup> regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotasGraham J Britton, Eduardo J Contijoch, Matthew P Spindler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative ColitisParakkal Deepak, Quazim A Alayo, Aava Khatiwada, et al.
Inflammatory Bowel Diseases|February 8, 2013
Quality indicators for inflammatory bowel disease: development of process and outcome measuresGil Y Melmed, Corey Allan Siegel, Brennan M Spiegel, et al.
Immunity|January 17, 2019
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt<sup>+</sup> Regulatory T Cells and Exacerbate Colitis in MiceGraham J Britton, Eduardo J Contijoch, Ilaria Mogno, et al.
Archives of Iranian Medicine|February 7, 2022
Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease: Comparison with Household Members and the Role of IBD MedicationsAli Reza Sima, Bahar Saberzadeh-Ardestani, Homayoon Vahedi, et al.
Lancet (London, England)|November 4, 2017
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trialJean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, et al.
The American Journal of Gastroenterology|January 26, 2024
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter ExperienceJeffrey A Berinstein, Taylor Karl, Anish Patel, et al.
Alimentary Pharmacology & Therapeutics|December 24, 2019
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's diseaseParambir S Dulai, Aurelien Amiot, Laurent Peyrin-Biroulet, et al.
Gastroenterology|February 12, 2020
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's DiseaseWilliam J Sandborn, Brian G Feagan, Edward V Loftus, et al.
Pageof 47

Showing results (401-410 of 463) with videos related to

Sort By:
Pageof 47
Gastroenterology|May 7, 2020
Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated DiseasesEli Stahl, Giulia Roda, Amanda Dobbyn, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
Defined microbiota transplant restores Th17/RORγt<sup>+</sup> regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotasGraham J Britton, Eduardo J Contijoch, Matthew P Spindler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative ColitisParakkal Deepak, Quazim A Alayo, Aava Khatiwada, et al.
Inflammatory Bowel Diseases|February 8, 2013
Quality indicators for inflammatory bowel disease: development of process and outcome measuresGil Y Melmed, Corey Allan Siegel, Brennan M Spiegel, et al.
Immunity|January 17, 2019
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt<sup>+</sup> Regulatory T Cells and Exacerbate Colitis in MiceGraham J Britton, Eduardo J Contijoch, Ilaria Mogno, et al.
Archives of Iranian Medicine|February 7, 2022
Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease: Comparison with Household Members and the Role of IBD MedicationsAli Reza Sima, Bahar Saberzadeh-Ardestani, Homayoon Vahedi, et al.
Lancet (London, England)|November 4, 2017
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trialJean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, et al.
The American Journal of Gastroenterology|January 26, 2024
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter ExperienceJeffrey A Berinstein, Taylor Karl, Anish Patel, et al.
Alimentary Pharmacology & Therapeutics|December 24, 2019
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's diseaseParambir S Dulai, Aurelien Amiot, Laurent Peyrin-Biroulet, et al.
Gastroenterology|February 12, 2020
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's DiseaseWilliam J Sandborn, Brian G Feagan, Edward V Loftus, et al.
Pageof 47